Cargando…
Perampanel-Induced, New-Onset Thrombocytopenia in a Patient With Refractory Seizures: A Case Report
Perampanel (Fycompa) is a glutamate receptor antagonist known to be a safe, effective, and well-tolerated medication; nevertheless, adverse effects are possible. This case report aims to raise the suspicion of perampanel-induced thrombocytopenia and discuss its possible pathways implicated. Here, we...
Autores principales: | Almuhanna, Rakan A, Muddassir, Rabia, Almaghrabi, Murouj, Bokhari, Gadir, Al-Ghamdi, Abdulazuiz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195002/ https://www.ncbi.nlm.nih.gov/pubmed/37213988 http://dx.doi.org/10.7759/cureus.37781 |
Ejemplares similares
-
Marked Efficacy of a Therapeutic Strategy in a Patient With Necrotizing Myopathy Associated With Anti-signal Recognition Particle (SRP) Autoantibodies
por: Almaghrabi, Murouj, et al.
Publicado: (2023) -
Pneumomediastinum and Pneumopericardium as Uncommon Complications of COVID-19 Infection: A Review Article
por: Alsulaihebi, Amjad S, et al.
Publicado: (2022) -
Atorvastatin-Induced Refractory Thrombocytopenia
por: Ghuman, Jasmine, et al.
Publicado: (2021) -
Improvement of "Bouncy Gait" in Lance-Adams Syndrome with Perampanel
por: Lim, Shen-Yang, et al.
Publicado: (2020) -
Neurocysticercosis Presenting With a New-Onset Seizure: A Case Report
por: Lim, William, et al.
Publicado: (2021)